Lack of pharmacokinetic interaction between tiagabine and erythromycin

Journal of Clinical Pharmacology

Volumn 38, Issue 11, 1998, Pages 1051-1056

  Thomsen, Mikael Søndergård ^a   Groes, Lisbet ^a   Agersø, Henrik ^a   Kruse, Trine ^a  

^a NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ERYTHROMYCIN; TIAGABINE;

ADULT; ANTIBIOTIC THERAPY; ANTICONVULSANT THERAPY; AREA UNDER THE CURVE; ARTICLE; ASTHENIA; CLINICAL TRIAL; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG INDUCED DISEASE; DRUG METABOLISM; DRUG SAFETY; FEMALE; FLATULENCE; HEADACHE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; SEIZURE; VERTIGO;

EID: 0031725752     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/009127009803801110     Document Type: Article

References (23)

1. Ben-Menachem E: International experience with tiagabine add-on therapy. Epilepsia 1995:36(suppl 6):S14-S21.
2. Leppik IE: Tiagabine: the safety landscape. Epilepsia 1995;36(suppl 6):S10-S13.
3. Schachter SC: Tiagabine monotherapy in the treatment of partial epilepsy. Epilepsia 1995;36(suppl 6):S2-S6.
4. Schachter SC: Tiagabine: current status and potential clinical applications. Exp Opin Invest Drugs 1996;5:1377-1387.
5. 14C]tiagabine by human hepatic microsomes (abstract). Epilepsia 1995;36(suppl 3):S159.
6. Gustavson LE, Cato A, Boellner SW, Cao GX, Qian JX, Guenther HJ, Sommerville KW: Lack of pharmacokinetic drug interactions between tiagabine and carbamazepine or phenytoin. Online J Curr Clin Trials [serial online] February 3, 1997; document no. 202.
7. Gustavson LE, Sommerville KW. Boellner SW, Witt GF, Guenther HJ, Granneman GR: Lack of clinically significant pharmacokinetic drug interaction between tiagabine and valproate. Online J Curr Clin Trials [serial online] February 18, 1997; document no. 203.
8. So EL, Wolff D, Graves NM, Leppik IE, Cascino GD, Pixton GC, Gustavson LE: Pharmacokinetics of tiagabine as add-on therapy in patients taking enzyme-inducing antiepilepsy drugs. Epilepsy Res 1995;22:221-226.
9. Larrey D, Funck-Bretano C, Breil P, Vitaux J, Theodore C, Babany G, Pessayre D: Effects of erythromycin on hepatic drug-metabolizing enzymes in humans. Biochem Pharmacol 1983;32:1063-1068.
10. von Rosenstiel N-A, Adam D: Macrolide antibacterials: drug interactions of clinical significance. Drug Safety 1995;13:105-122.
11. Janssens J, Peeters TL, Vantrappen G, Tack J, Urbain JL, De Roo M, et al: Improvement of gastric emptying in diabetic gastroparesis by erythromycin. N Engl J Med 1990;322:1028-1031.
12. Urbain JLC, Vantrappen G, Janssens J, Van Cutsem E, Peeters T. De Roo M: Intravenous erythromycin dramatically accelerates gastric emptying in gastroparesis diabeticorum and normals and abolishes the emptying discrimination between solids and liquids. J Nucl Med 1990;31:1490-1493.
13. Gustavson LE, Chu S: High performance liquid Chromatographic procedure for the determination of tiagabine concentrations in human plasma using electrochemical detection. J Chromatogr 1992;574:313-318.
14. Laakso S, Scheinin M, Anttila M: Determination of erythromycin base and 2-acetylerythromycin in human plasma using high performance liquid chromatography with electrochemical detection. J Chromatogr 1990;526:475-486.
15. Gibaldi M, Perrier D: Pharmacokinetics. Second edition. New York: Marcell Dekker, 1982.
16. Snel S, Jansen JA, Pedersen PC, Jorkman JHG, van Heiningen PNM: Tiagabine, a novel antiepileptic agent: lack of pharmacokinetic interaction with digoxin. Eur J Clin Pharmacol 1998;54:355-357.
17. Datz FL, Christian PE, Moore J: Gender-related differences in gastric emptying. J Nucl Med 1987;28:1204-1207.
18. Gleiter CH, Gundert-Remy U: Gender differences in pharmacokinetics. Eur J Drug Metab Pharmacokinet 1996;21:123-128.
19. Ludden TM: Pharmacokinetic interactions of the macrolide antibiotics. Clin Pharmacokinet 1985;10:63-79.
20. Gascon MP, Dayer P: Comparative effects of macrolide antibiotics on liver monooxygenases. Clin Pharmacol Ther 1991;49:158.
21. Pessayre D, Larrey D, Funck-Bretano C, Benhamou JP: Drug interactions and hepatitis produced by some macrolides. J Antimicrob Chemother 1985;16(suppl A):181-194.
22. Kobayashi K, Chiba K, Yagi T, Shimada N, Taniguchi T, Horie T, et al: Identification of cytochrome P450 isoforms involved in citalopram N-demethylation by human liver microsomes. J Pharmacol Exp Ther 1997;280:927-933.
23. Brodie MJ: Tiagabine pharmacology in profile. Epilepsia 1995;36(suppl 6):S7-S9.